About US
Contact us
-
Merck and Simcere Sign Agreement to Establish PioneeringPartnership Focused on Providing Significantly Enhanced Access to Quality Medicines for Chinese Patients WHITEHOUSE STATION, N.J., and NANJING, China, July 21, 2011 – Merck & Co., Inc., Whiteh2011/7/25
-
SFDA issues technical guidelines for clinical research of TCM and natural medicine treating angina pectoris and female climacteric syndromeIn order to scientifically standardize and guide the clinical research of traditional Chinese medicine (TCM) and natural medicines and ensure research quality, the State Food and Drug Administration (2011/7/22
-
Roche, Merck sign new non-exclusive agreement for HCV triple combination therapyMerck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has signed a new non-exclusive agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY), through the companies' r2011/7/22
-
Purdue Pharma develops new online resource for combating prescription drug abuseA new online resource, RxSafetyMatters.org, is now available to help healthcare professionals, law enforcement, and community organizations combat the illegal diversion and abuse of prescription medic2011/7/21
-
New transgenic mouse could predict toxicity of targeted cancer drugsOnly one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinic2011/7/21
-
Patients who use anti-depressants more likely to suffer relapsesPatients who use anti-depressants are much more likely to suffer relapses of major depression than those who use no medication at all, concludes a McMaster researcher. In a paper that is likely to2011/7/20
-
New transgenic mouse for recognizing cancer drug side effectsResearchers are able to precisely simulate the inhibition of genes with new cancer drugs Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product2011/7/20
-
Woodcock: New drug approvals reach 20-year highIs it too soon for the FDA to call 2011 a good year for drug approvals? Maybe not. CDER director Janet Woodcock claims that new chemical and molecular entity approvals have reached a 20-year high, and2011/7/19
-
U.S. FDA approves 2011-2012 influenza vaccine formulationThe U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce an2011/7/19
-
Transcept decreases workforce to reduce expenses following FDA news on Intermezzo NDATranscept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today plans to reduce operating expenses by eliminating approximately 45% of its workforce following notification from the U.S. Food and Drug A2011/7/18